The Future of Circulating Tumor DNA in Endometrial and Gynecologic Cancer

We need to do better and follow our medical oncology colleagues and do more circulating DNA. We don't really have that in endometrial cancer. For bigger volume disease, yes, circulating tumor DNA seems to predict that. But for these very early, you know, we're not sure yet. It's not quite as robust as we'd like, based on the preliminary data. Stay tuned.